Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin and ART for Cardiovascular Risk in HIV
NCT00783614Phase 2Terminated
- Sponsor
- Hennepin Healthcare Research Institute
- Start
- Oct 2008
- Primary completion
- Jan 2010
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of aspirin in cardiovascular disease (CVD), sponsored by Hennepin Healthcare Research Institute. Started Oct 2008; status: terminated.
02
Drugs
aspirin
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT00783614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00783614.